CGHC (CGHC) Stock Price & Analysis
CGHC (CGHC) rose 0.00% to USD 0 as of June 11, 2026 at 03:33 UTC, according to Nexqual real-time market data.
CGHC last closed at USD 0; the session ranged USD 0–0 on volume of 1,065,200 shares. Market capitalization is $9,219, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 11, 2026 at 03:33 UTC.
Key Statistics (as of June 11, 2026 at 03:33 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 1,065,200 shares |
| Market Cap | $9,219 |
| Exchange | PNK |
Technical Analysis (CGHC)
Nexqual's technical model rates CGHC "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 11, 2026 at 03:33 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (CGHC)
Wall Street analysts rate CGHC "None", per Nexqual as of June 11, 2026 at 03:33 UTC.
| Consensus Rating | None |
|---|
Earnings (CGHC)
Source: Nexqual, June 11, 2026 at 03:33 UTC.
Financials & Fundamentals (CGHC)
| Total Revenue | $4.33M |
|---|---|
| Gross Margin | +20.38% |
| Operating Margin | -23.62% |
| Profit Margin | -45.99% |
| ROE | -44.65% |
| Debt / Equity | 12.22 |
| Current Ratio | 0.53 |
| Total Cash | $817,289 |
| Total Debt | $1.22M |
| Free Cash Flow | $-1.07M |
Source: Nexqual, June 11, 2026 at 03:33 UTC.
Financial Health Score (CGHC)
Nexqual rates CGHC's overall financial health "Weak" across five dimensions, as of June 11, 2026 at 03:33 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Solid — $817K cash vs $1M debt |
| Cash Flow | Weak — FCF negative: -$1M, burning cash |
| Efficiency | Critical — ROE -45%, ROA -18.1% |
Ownership (CGHC)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 92.20M |
Source: Nexqual, June 11, 2026 at 03:33 UTC.
Leadership (CGHC)
CGHC is led by Michael Blumhoff, Chairman & CEO, per Nexqual as of June 11, 2026 at 03:33 UTC.
| Chairman & CEO | Michael Blumhoff |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| 2121.HK | AINNOVATION | HKD 3.89 | ▼ 2.26% |
| CGNH | CARDIOGENICS HOLDINGS INC | USD 0 | ▲ 0% |
| CRVW | Careview Communications, Inc. | USD 0.05 | ▲ 0% |
| ARNI | ARNO THERAPEUTICS INC | USD 0 | ▼ 50% |
| PFND | PATHFINDER CELL THERAPY INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 11, 2026 at 03:33 UTC. This page is informational and not investment advice.